What Are The Primary Underlying Causes Of Under-Eye Dark Circles, And How Should Aesthetic Clinics Select Appropriate Treatment Modalities Such As Laser Therapy?

Under-eye dark circles are not one condition. Their primary causes are pigmentary darkening, vascular show-through, and anatomical shadowing from volume loss—often occurring in combination. Clinics should first identify the dominant mechanism through examination under different lighting and at rest versus smiling; only then should they select laser therapy, topical treatment, filler, or a combination approach.

The correct treatment depends on the cause, not simply on how dark the under-eye area appears. Pigment lasers address melanin, not hollowness or vascular visibility, while structural shadowing generally requires volume restoration rather than surface resurfacing.

Identify What Is Creating the Dark Appearance

Hyperpigmentation: excess melanin

Pigmentary dark circles result from increased melanin in the epidermis or dermis. Common contributors include sun exposure, genetics, prior inflammation, rubbing, and post-inflammatory hyperpigmentation.

The skin may appear brown, gray-brown, or more distinctly pigmented when compared with surrounding facial skin. Pigment often becomes more apparent under direct illumination rather than changing substantially with facial expression.

Vascular visibility: thin skin and blood-related coloration

The lower eyelid has very thin skin, allowing underlying vessels and venous coloration to show through. This can create blue, purple, or red-brown discoloration, particularly in patients with thin skin or prominent superficial vasculature.

This mechanism is better described as vascular show-through or pooling than as a universal process of blood “leaking” from capillaries. Topical strategies, skin-quality improvement, and selected vascular treatments may be more appropriate than pigment-targeting lasers.

Anatomical shadowing: hollows and contour changes

Tear-trough hollowing creates a shadow that can resemble pigmentation even when the skin contains little excess melanin. Age-related fat redistribution, subcutaneous volume loss, ligamentous anatomy, and orbital contour all contribute.

A useful clinical clue is that the darkness changes with lighting, head position, or facial expression. In these cases, a pigment laser will not correct the underlying shadow.

Mixed causes are common

Many patients have more than one contributor—for example, mild brown pigmentation combined with thin translucent skin and tear-trough hollowing. Treating only one component can produce limited improvement and may lead to unnecessary escalation of treatment.

Match the Treatment to the Etiology

When laser therapy is appropriate

Laser or light-based treatment is most relevant when melanin is a major contributor. Depending on pigment depth, skin phototype, and the diagnosis, clinicians may consider pigment-selective systems, fractional non-ablative devices, or carefully selected resurfacing approaches.

The objective is to reduce or remodel pigment while limiting inflammation. The treatment should be conservative because periocular skin is thin and particularly vulnerable to thermal injury and pigmentary complications.

When chemical exfoliation may be preferable

Superficial pigment may respond to appropriately selected chemical exfoliants or topical pigment-regulating agents. These approaches can be useful when the pigment is mild, epidermal, or associated with ongoing irritation.

Periocular application requires particular caution. Formulation strength, treatment distance from the eyelid margin, ocular protection, and the patient’s history of sensitivity should all influence the protocol.

When vascular or skin-quality treatment is more suitable

If vascular show-through dominates, a pigment laser may offer little benefit. Management may instead involve vascular-targeted evaluation, barrier repair, topical formulations, and measures that improve skin quality or reduce chronic irritation.

Clinicians should also assess allergic or irritant dermatitis, habitual rubbing, eczema, and other inflammatory conditions that can worsen both vascular visibility and secondary pigmentation.

When fillers or structural correction are indicated

Prominent tear-trough shadowing caused by volume loss is generally treated with carefully selected soft-tissue filler or another structural volume-restoration strategy, not a surface pigment laser.

Patient selection is critical. Filler may be inappropriate when the main issue is edema, prominent fat pads, malar bags, significant skin laxity, or a tendency toward persistent swelling.

How Clinics Should Select a Laser Modality

Start with pigment depth and diagnosis

The device should be chosen according to whether the pigment is superficial, deeper, mixed, or actually misidentified shadowing. A generic “dark-circle laser” is not a sound treatment category.

A proper assessment should distinguish melanin from vascular coloration, contour shadow, active dermatitis, and less common causes of periorbital discoloration. A new, unilateral, rapidly changing, or symptomatic finding warrants medical evaluation rather than cosmetic treatment alone.

Account for skin phototype

Darker skin phototypes have a greater risk of post-inflammatory or post-resurfacing hyperpigmentation. Laser-induced thermal stress can stimulate melanogenesis, particularly when treatment is too aggressive or the diagnosis is uncertain.

For appropriate resurfacing indications in darker skin, Er:YAG may offer a smaller thermal footprint than CO₂ and may therefore reduce, but not eliminate, the risk of inflammation-related pigment alteration. This does not make Er:YAG risk-free or automatically suitable for every patient.

Use conservative energy and staged treatment

Periocular treatment should prioritize controlled endpoints over maximum energy. Test spots, conservative fluence, adequate treatment intervals, and standardized photography can help clinicians evaluate response before escalating.

Aggressive single-pass treatment is particularly unsuitable when the diagnosis resembles melasma or when the patient has a history of post-inflammatory hyperpigmentation. Rebound darkening can make the original concern worse.

Consider the likely pigment location

Pigment-selective wavelength decisions should reflect pigment depth and skin type. In broad terms, superficial epidermal pigment absorbs shorter visible wavelengths more strongly, while deeper dermal pigment may require longer wavelengths with lower epidermal melanin absorption.

However, under-eye discoloration is not automatically equivalent to a discrete pigmented lesion. Applying protocols designed for solar lentigines, nevus of Ota, or other lesions without confirming the diagnosis can produce poor results or unnecessary risk.

Protect the Eye and the Periocular Skin

Use appropriate ocular protection

Treatment near the orbit requires protection selected for the device wavelength and treatment location. For areas outside the orbital rim, external wavelength-specific shields or metal goggles may be suitable when correctly applied.

For treatment within the orbital rim, properly inserted metal corneal shields may be required. Their use should be limited to trained clinicians who understand insertion, removal, anesthesia, and corneal-injury prevention.

Avoid relying on adhesive protection alone

Adhesive shields must fully adhere to the skin. Tears, skin oils, and moisture can compromise adhesion and create gaps in protection.

Clinics should follow the laser manufacturer’s safety requirements and maintain a protocol for eye examination, device settings, plume management, and emergency response.

Prevent pigmentary complications

Photoprotection and control of inflammation are central to treatment success. Patients should avoid rubbing the area and follow a clinician-directed post-treatment regimen.

In patients at high risk of hyperpigmentation, topical pigment-regulating or bleaching agents may be considered by an appropriately qualified clinician. They should not be applied prematurely to compromised skin; timing should follow complete re-epithelialization where resurfacing has occurred.

Understanding the Trade-offs

Laser cannot correct every dark circle

A pigment laser will not remove a tear-trough shadow, correct orbital volume loss, or reliably eliminate blue coloration caused by vascular visibility. Treating the wrong mechanism can lead to repeated procedures without meaningful improvement.

More aggressive treatment is not necessarily better

Higher energy or deeper resurfacing may increase inflammation, downtime, and the risk of post-inflammatory pigmentation. The periocular region has little tolerance for avoidable thermal injury.

Localized treatment can create visible boundaries

When resurfacing is performed only on a small periocular area, a contrast line may become visible between treated and untreated skin. Broader treatment fields may sometimes create a more uniform result, but full-face resurfacing also increases cost, downtime, and risk.

The “panda bear” concern is therefore a planning issue, not a reason to treat every patient with full-face laser. The treatment area should be based on the distribution of the problem and the patient’s risk-benefit profile.

Filler has its own limitations

Under-eye filler can improve contour shadowing but may cause persistent edema, bluish discoloration, lumpiness, asymmetry, or an unnatural transition when poorly selected or placed. It is not a substitute for diagnosing pigment or vascular causes.

Expectations must be realistic

Dark circles may improve rather than disappear. The clinician should explain which component is being treated, what will remain untreated, how many sessions may be required, and what risks are increased by the patient’s skin type or medical history.

Making the Right Choice for Your Goal

A reliable clinic should document the dominant cause, identify mixed contributors, and select the least aggressive modality capable of addressing that cause.

If your primary focus is hyperpigmentation: Use a conservative, diagnosis-specific pigment or resurfacing protocol selected for pigment depth and skin phototype, with strict photoprotection and monitoring for post-inflammatory darkening.
If your primary focus is vascular show-through: Prioritize assessment of superficial vessels, thin skin, irritation, and barrier health rather than assuming a melanin-targeting laser is appropriate.
If your primary focus is tear-trough shadowing: Evaluate structural volume loss and contour anatomy; consider volume-restoration options only when the patient is an appropriate candidate.
If your primary focus is darker skin phototypes: Favor conservative settings, test treatment where appropriate, and select lower-thermal-injury approaches while recognizing that no laser eliminates pigmentary risk.
If your primary focus is a natural overall result: Treat the dominant cause first, avoid unnecessary modality combinations, and assess whether a broader treatment field is needed to prevent visible demarcation.

The safest and most effective under-eye treatment begins with identifying what is creating the darkness, then matching the modality to that specific mechanism.

Summary Table:

Cause	Description	Appropriate Treatment
Hyperpigmentation	Excess melanin in the skin	Pigment lasers, chemical exfoliants, topical agents
Vascular show-through	Thin skin revealing blood vessels	Vascular treatments, skin barrier repair, topical care
Anatomical shadowing	Volume loss creating hollows	Fillers or structural volume restoration
Mixed causes	Combination of the above	Combination therapy tailored to individual needs

Ready to refine your under-eye treatment protocols? BELIS offers advanced aesthetic lasers, IPL, and body sculpting devices trusted by clinics and premium salons. Contact our experts today to elevate your practice and achieve outstanding results for your patients. Contact us now.